Ontotext opens new office in the Basel Area
Ontotext, a company based in New York City and the Bulgarian capital of Sofia, has opened a new location at the Switzerland Innovation Park Basel Area. The experts in enterprise knowledge graph technology and semantic database engines were supported in this process by Basel Area Business & Innovation.
Ontotext has opened a new office at the Allschwil site of the Switzerland Innovation Park Basel Area located in the canton of Basel-Landschaft. The global supplier of enterprise knowledge graph technology and semantic database engines, headquartered in the Bulgarian capital of Sofia with an office in New York City, specializes in the field of life sciences and healthcare. With a comprehensive database of life sciences terminology, ontologies and data sources, Ontotext supports its clients in their efforts to generate usable insights from data.
“Selecting Basel Area as the location for our development in Switzerland and the DACH region will help Ontotext stay even closer to our customers and align our innovative products and solutions to the constantly growing and changing needs of the Life Sciences businesses we serve”, comments Todor Primov, Head of Life Sciences and Healthcare, in a press release issued by Ontotext.
The Basel Area boasts “global impact”, explains Ilian Uzunov, Sales Director Life Sciences and Healthcare at Ontotext. This location will “help us innovate at scale and stay in touch with the latest trends in Biotech, Medtech and Digital Health”, he adds.
The investment and innovation promotion agency Basel Area Business & Innovation supported Ontotext in the process of establishing the business in the region, by helping with the search for suitable premises and providing information in relation to employee secondments in Switzerland, for example.
Share this article
You may also be interested in
Artificial Intelligence (AI) offers numerous possible applications. But how, where and regarding which focal points can you get further training...Read More
Cimeio Therapeutics from Basel has received initial financing amounting to 46 million Swiss francs from Versant Ventures. The startup is...Read More